MFN2 and amyotrophic lateral sclerosis: In their previously mentioned work, Russell et al. 10 employed both in vitro and in vivo models to understand the specific biological consequences of the novel MFN2 variants disclosed in their amyotrophic lateral sclerosis cohort.